Aptose Biosciences News

Aptose Biosciences | DEF 14A: Definitive information statements

May 15 23:50

Aptose Biosciences | 10-Q: Quarterly report

May 15 05:11

Aptose Biosciences | 8-K: Aptose Reports Results for the First Quarter 2024

May 15 04:21

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities- LEDRU PHILIPPE

May 10 23:39

Aptose Biosciences | 8-K: Current report

May 7 04:50

Aptose Biosciences | 8-K: Current report

May 2 04:35

Aptose Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

May 1 05:27

Aptose Biosciences | 10-K/A: Annual report (Amendment)

Apr 30 05:22

Aptose Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hanmi Pharmaceutical Co., Ltd.(19.02%)

Apr 27 00:58

Aptose Biosciences | 8-K: Current report

Apr 26 19:33

Aptose Biosciences | 8-K: Current report

Apr 6 05:10

Aptose Biosciences | 10-K: Annual report

Mar 27 05:05

Aptose Biosciences | 8-K: Aptose Reports Results for the Fourth Quarter and Full Year 2023

Mar 27 04:08

Aptose Biosciences | 8-K: Current report

Mar 19 04:46

Aptose Biosciences | 8-K: Current report

Mar 2 06:07

Aptose Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(1.5%),Wilmot B. Harkey(1.5%), etc.

Feb 15 05:58

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Payne Fletcher

Feb 8 07:12

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Bejar Rafael

Feb 8 06:47

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer LEDRU PHILIPPE

Feb 8 06:27

Aptose Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Rice William G.

Feb 8 06:18